\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tThe National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 39 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013.<\/p>\n
The formulations cover a wide range of medicines, including those used to treat hypertension, diabetes, HIV, heart disease and eye infections, with the aim of making them more affordable for patients.<\/p>\n
The notification was issued on July 8. It is a retail price fixation order for new drug formulations under the DPCO, 2013, and not a price reduction order.<\/p>\n
Among the medicines included, Amlodipine + Bisoprolol + Telmisartan Tablets, used for the treatment of hypertension (high blood pressure), have been fixed at Rs 14.74 per tablet.<\/p>\n
The retail price of Nepafenac + Moxifloxacin Ophthalmic Solution, an eye drop used after eye surgery and for the treatment of bacterial eye infections, has been fixed at Rs 68.64 per ml.<\/p>\n
Similarly, Clopidogrel + Aspirin + Atorvastatin Capsules, which are used to reduce the risk of heart attack and stroke, have been priced at Rs 6.37 per capsule.<\/p>\n
The NPPA also reiterated that retailers and dealers are required to prominently display the price lists provided by manufacturers. — ANI\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n","protected":false},"excerpt":{"rendered":"The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 39 new drug formulations under the…\n","protected":false},"author":2,"featured_media":580281,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[274],"tags":[9,27012,18,135,19,2191,2810,17,245584,21187,462,245585,245583],"class_list":["post-580280","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-breaking-news","tag-columns","tag-eire","tag-health","tag-ie","tag-india-news","tag-interviews","tag-ireland","tag-live-commentary","tag-live-updates","tag-medication","tag-news-india","tag-rediff"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116901080371034933","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/580280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=580280"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/580280\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/580281"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=580280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=580280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=580280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}